Andraka-Christou B - Search Results

1

Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment.

Stein BD, Saloner BK, Golan OK, Andraka-Christou B, Andrews CM, Dick AW, Davis CS, Sheng F, Gordon AJ. Stein BD, et al. JAMA Health Forum. 2023 May 5;4(5):e231102. doi: 10.1001/jamahealthforum.2023.1102. JAMA Health Forum. 2023. PMID: 37234015 Free PMC article.

2

AMERICA NEEDS THE TREAT ACT: EXPANDING ACCESS TO EFFECTIVE MEDICATION FOR TREATING ADDICTION.

Andraka-Christou B. Andraka-Christou B. Health Matrix Clevel. 2016;26:309-62. Health Matrix Clevel. 2016. PMID: 27263255 No abstract available.

3

A Pressing Need for Pharmacotherapy Development to Treat Drug Addiction: An Editorial from a Legal Perspective.

Andraka-Christou B. Andraka-Christou B. Int Rev Neurobiol. 2016;126:15-38. doi: 10.1016/bs.irn.2016.02.003. Epub 2016 Mar 14. Int Rev Neurobiol. 2016. PMID: 27055610

4

Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.

Randall-Kosich O, Andraka-Christou B, Totaram R, Alamo J, Nadig M. Randall-Kosich O, et al. J Addict Med. 2020 Jul/Aug;14(4):e44-e52. doi: 10.1097/ADM.0000000000000584. J Addict Med. 2020. PMID: 31651562

5

Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder.

Nguyen T, Andraka-Christou B, Simon K, Bradford WD. Nguyen T, et al. JAMA Netw Open. 2019 Dec 2;2(12):e1916520. doi: 10.1001/jamanetworkopen.2019.16520. JAMA Netw Open. 2019. PMID: 31790568 Free PMC article.

6

College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.

Andraka-Christou B, Nguyen T, Harris S, Madeira J, Totaram R, Randall-Kosich O, Atkins D, Ford J. Andraka-Christou B, et al. Am J Drug Alcohol Abuse. 2020 Sep 2;46(5):589-603. doi: 10.1080/00952990.2020.1757686. Epub 2020 Jun 16. Am J Drug Alcohol Abuse. 2020. PMID: 32543922

7

A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.

Haffajee RL, Andraka-Christou B, Attermann J, Cupito A, Buche J, Beck AJ. Haffajee RL, et al. Subst Abuse Treat Prev Policy. 2020 Sep 14;15(1):69. doi: 10.1186/s13011-020-00312-3. Subst Abuse Treat Prev Policy. 2020. PMID: 32928272 Free PMC article.

8

Whose opinion matters about medications for opioid use disorder? A cross-sectional survey of social norms among court staff.

Andraka-Christou B, Atkins DN. Andraka-Christou B, et al. Subst Abus. 2021;42(4):735-750. doi: 10.1080/08897077.2020.1846666. Epub 2020 Dec 7. Subst Abus. 2021. PMID: 33284059

9

The Association Between Scope of Practice Regulations and Nurse Practitioner Prescribing of Buprenorphine After the 2016 Opioid Bill.

Nguyen T, Muench U, Andraka-Christou B, Simon K, Bradford WD, Spetz J. Nguyen T, et al. Med Care Res Rev. 2022 Apr;79(2):290-298. doi: 10.1177/10775587211004311. Epub 2021 Apr 1. Med Care Res Rev. 2022. PMID: 33792414 Free PMC article.

10

It will end in tiers: A strategy to include "dabblers" in the buprenorphine workforce after the X-waiver.

Saloner B, Andraka Christou B, Gordon AJ, Stein BD. Saloner B, et al. Subst Abus. 2021;42(2):153-157. doi: 10.1080/08897077.2021.1903659. Epub 2021 Apr 2. Subst Abus. 2021. PMID: 33798034 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters